Enclomiphene: UK Status and Risks
Enclomiphene is not a UK-licensed product under UK medicines law. It may still appear in some catalogs, but the MHRA has not evaluated it.
Ask a doctor or pharmacist before relying on it, and be cautious of sellers making strong claims about it. A missing or unclear UK licensing status is a reasonable thing to question.
Not UK-licensed. This medicine is not supplied through UK-registered pharmacies.
Sellers list the active ingredient as enclomiphene. The MHRA has not assessed what these products actually contain.
The MHRA warns that medicines sold outside registered pharmacies can be counterfeit, contaminated, or contain the wrong amount of active ingredient. Buy prescription-only medicines from a pharmacy registered in the UK.
Pharmacies by area for Enclomiphene (UK-licensed equivalent)
- North East · 884 pharmacies
- North West · 2538 pharmacies
- Yorkshire and The Humber · 1676 pharmacies
- East Midlands · 1307 pharmacies
- West Midlands · 1778 pharmacies
- East of England · 1860 pharmacies
- London · 3261 pharmacies
- South East · 2368 pharmacies
- South West · 1374 pharmacies
- Northern Ireland · 714 pharmacies
- Scotland · 1725 pharmacies
- Wales · 1050 pharmacies
Pharmacies near you
Use your location to open the pharmacies closest to you and ask them about Enclomiphene, the UK-licensed medicine with the same active ingredient.
Cities with the most pharmacies
- London · 724 pharmacies
- Birmingham · 265 pharmacies
- Nottingham · 180 pharmacies
- Glasgow · 177 pharmacies
- Leeds · 173 pharmacies
- Sheffield · 162 pharmacies
- Bristol · 148 pharmacies
- City of London · 144 pharmacies
- Manchester · 134 pharmacies
- Edinburgh · 131 pharmacies
- Bolton · 124 pharmacies
- Belfast · 122 pharmacies
- Hampstead · 121 pharmacies
- Coventry · 115 pharmacies
- Cardiff · 112 pharmacies
About Enclomiphene
Enclomiphene is not a licensed medicine in the United Kingdom and cannot legally be sold there as a medicine. It is also known as Androxal and Enclomifeno.
No product strengths or dosage forms are listed, and generic availability is unknown. Its potential hormonal effects need clinical assessment; an advertisement alone does not establish its quality, safety or suitability.
Claimed strengths are manufacturer claims; no claimed strengths or dosage forms are listed for Enclomiphene. There is consequently no stated strength to assess or compare with a licensed equivalent. This absence of product details does not establish a suitable dose, and this page does not provide a dosing schedule.
What Enclomiphene is used for
The marketing material does not specify a condition that Enclomiphene is claimed to treat. It therefore does not establish a particular marketed indication or a treatment benefit for this product.
Enclomiphene is associated with the selective oestrogen receptor modulator class, which affects hormonal signalling, but that mechanism alone does not demonstrate that a particular product is effective for a particular condition. Any advertised treatment claims should be discussed with a doctor or pharmacist rather than treated as established medical facts.
How Enclomiphene works
Enclomiphene acts through selective modulation of oestrogen receptors. These receptors are sites where oestrogen signals to cells. Medicines with this type of action can block some oestrogen signals while having different effects in other tissues.
Blocking oestrogen feedback in the brain can alter the signals sent to the reproductive glands, potentially increasing the body's own production of sex hormones. This general mechanism does not establish the composition, effectiveness or safety of a particular marketed product.
Key warnings
- Not licensed as a medicine in the United Kingdom; product quality and composition have not been independently verified.
- Selective oestrogen receptor modulators can cause visual disturbances, which require prompt medical assessment.
- This drug class can increase the risk of blood clots; a history of clotting problems requires clinical review.
- Hormonal effects may be unsuitable in people with certain hormone-sensitive conditions or liver disease.
Main interactions
- Other hormonal treatments may alter or oppose the intended hormonal effects.
- Oestrogen-containing medicines require review because of overlapping receptor effects and clotting concerns.
- Fertility medicines may have additive hormonal effects and require specialist supervision.
- Medicines that affect blood clotting warrant review where a selective oestrogen receptor modulator is being considered.
Missed dose
No product-specific missed-dose guidance is listed for Enclomiphene. For hormonal treatments, the appropriate response depends on the prescribed regimen and the reason for treatment. A doctor or pharmacist should clarify any interruption; an extra dose should not be assumed to compensate for a missed dose.
Pregnancy and breastfeeding
The marketing material does not specify pregnancy or breastfeeding data for Enclomiphene. Medicines that alter oestrogen signalling can affect reproductive processes and are generally unsuitable during pregnancy.
Safety during breastfeeding cannot be assumed. Pregnancy plans, possible pregnancy and breastfeeding should be discussed with a doctor or pharmacist before considering this product.
Storage
No storage conditions or dosage form are listed for this product. General medicine storage practice is to follow the packaging instructions, keep the original container secure and keep it out of the sight and reach of children.
Related medicines
First published October 2, 2026 · Last updated · Report an error on this page